INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/24/2025
Back to search
Official data from USPTO
CELL2SPHERE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CELL2SPHERE
ST13
US500000079205802Class
1, 5, 42
Filing
79205802
Registration
5420462
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
10/25/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/22/2016
Registration date
03/13/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2024
Last transaction
10/25/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
ES
Examiner
RIEPEL,CHRISTINA MAXINE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. S. (pessoa física)
Representatives
GORDON E R TROY Gordon E. R. Troy, PC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for commercial and scientific purposes, other than for medical or veterinary use; biological tissue cultures, cells and cell culture media, other than for medical or veterinary purposes, namely, for scientific and research use; kits for scientific and research use comprised of biological tissue cultures, cells and cell culture media, not for medical or veterinary purposes; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to drug discovery; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to scientific research; kits for scientific and research use comprised primarily of chemical compounds and culture medium for cell culture analysis and also containing plastic laboratory plates
Class 5
Pharmaceuticals, namely, biological tissue cultures and cell cultures for medical or clinical use; pharmaceuticals for use in the fields of oncology and hepatology; pharmaceuticals for the treatment of cancer and hepatic diseases; medical preparations, namely, biological tissue cultures for medical, veterinary and surgical purposes; diagnostic reagents for pharmaceutical, veterinary and medical use; diagnostic preparations for use in the fields of oncology and hepatology for pharmaceutical, veterinary and medical use; diagnostic preparations for the treatment of cancer and hepatic diseases for pharmaceutical, veterinary and medical use; diagnostic biomarker reagents for medical purposes; enzymes for medical and veterinary purposes; biological tissue cultures, living cells, cell culture media for growing cells and stem cells for medical and veterinary purposes; diagnostic cell cultures for medical and veterinary purposes
Class 42
Scientific, technological and design services, namely, technical research and design in the field of new pharmaceuticals; scientific research and development; research and development in the field of microorganisms and cells; scientific and technologic services, namely, industrial analysis and research services in the field of biotechnology and pharmaceuticals; scientific research consulting services relating to cell culture research and development in analytical or therapeutic fields; laboratory consulting services relating to the production of artificial biological tissue in analytical or therapeutic fields; scientific research consulting services relating to the use of biological tissue in analytical or therapeutic research fields; contract research services relating to biotechnology; laboratory research in the field of biotechnology and pharmaceuticals; drug discovery services; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells for diagnostic purposes
Publications
History of USPTO decisions and trademark events.
36 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/02/2025
INPC
INVALIDATION PROCESSED
10/02/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/27/2025
C71T
CANCELLED SECTION 71
09/27/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/16/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/16/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/10/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/26/2018
FIMP
FINAL DISPOSITION PROCESSED
06/26/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/13/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2017
PUBO
PUBLISHED FOR OPPOSITION
12/26/2017
GPNX
NOTIFICATION PROCESSED BY IB
12/22/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/06/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/10/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/13/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/13/2017
RFNT
REFUSAL PROCESSED BY IB
06/03/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/12/2017
RFRR
REFUSAL PROCESSED BY MPU
05/12/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/08/2017
CNRT
NON-FINAL ACTION WRITTEN
05/07/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/02/2017
DOCK
ASSIGNED TO EXAMINER
04/28/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/20/2017
Continuous trademark protection
Get notified about every new filing that threatens CELL2SPHERE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.